Literature DB >> 23261182

Ictal EEG fractal dimension in ECT predicts outcome at 2 weeks in schizophrenia.

Hulegar A Abhishekh1, Jagadisha Thirthalli, Anusha Manjegowda, Vivek H Phutane, Kesavan Muralidharan, Bangalore N Gangadhar.   

Abstract

Studies of electroconvulsive therapy (ECT) have found an association between ictal electroencephalographic (EEG) measures and clinical outcome in depression. Such studies are lacking in schizophrenia. Consenting schizophrenia patients receiving ECT were assessed using the Brief Psychiatric Rating Scale (BPRS) before and 2 weeks after the start of ECT. The patients' seizure was monitored using EEG. In 26 patients, completely artifact-free EEG derived from the left frontal-pole (FP1) channel and electrocardiography (ECG) were available. The fractal dimension (FD) was computed to assess 4-s EEG epochs, and the maximal value from the earliest ECT session (2nd, 3rd or 4th) was used for analysis. There was a significant inverse correlation between the maximum FD and the total score following 6th ECT. An inverse Inverse correlation was also observed between the maximum FD and the total number of ECTs administered as well as the maximum heart rate (HR) and BPRS scores following 6th ECT. In patients with schizophrenia greater intensity of seizures (higher FD) during initial sessions of ECT is associated with better response at the end of 2 weeks.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ECT; EEG; Fractal dimension; Ictal; Outcome

Mesh:

Year:  2012        PMID: 23261182     DOI: 10.1016/j.psychres.2012.11.029

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  1 in total

Review 1.  Two decades of an indigenously developed brief-pulse electroconvulsive therapy device: A review of research work from National Institute of Mental Health and Neurosciences.

Authors:  Preeti Sinha; A ShyamSundar; Jagadisha Thirthalli; B N Gangadhar; Vittal S Candade
Journal:  Indian J Psychiatry       Date:  2016 Jan-Mar       Impact factor: 1.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.